SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | n/a |
Enterprise Value ($M) | n/a |
Book Value ($M) | 7.38 |
Book Value / Share | n/a |
Price / Book | n/a |
NCAV ($M) | 7.37 |
NCAV / Share | n/a |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.29 |
Return on Assets (ROA) | -0.66 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.84 |
Current Ratio | 3.84 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 9.96 |
Assets | 9.97 |
Liabilities | 2.60 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 7.14 |
Operating Income | -7.01 |
Net Income | -2.17 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -7.45 |
Cash from Investing | 0.00 |
Cash from Financing | 11.15 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Ra Capital Management, L.p. | 9.99 | ||
13G/A | AI EIPP Holdings LLC | 0.74 | -90.06 | |
13D/A | Boger Joshua S | 17.10 | 88.36 | |
13D | Zavrl Frank | 6.40 | 0.00 | |
13D | Alam John J | 26.20 | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
2,803 | 30,139 | 9.30 | |
3,920 | 25,467 | 15.39 | |
4,702 | 5,739 | 81.93 | |
3,614 | 4,115 | 87.83 | |
2,832 | 8,445 | 33.53 | |
(click for more detail) |
Similar Companies | |
---|---|
CRBP – Corbus Pharmaceuticals Holdings, Inc. | CRDF – Cardiff Oncology, Inc. |
CRIS – Curis, Inc. | CSBR – Champions Oncology, Inc. |
CTXR – Citius Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io